| SCIENCE NEWS | Merrimack Pharmaceuticals’ Therapies Show Promise in Certain Advanced Breast, Gastric and Gynecologic Cancers Merrimack Pharmaceuticals, Inc. announced the presentation of Phase I safety and clinical results evaluating two potential new therapies with a novel target – ErbB3, a signaling receptor believed to be responsible for triggering tumor growth and resistance in a number of malignancies including breast, ovarian, gastric, esophageal and bladder cancers. The two studies were presented in poster sessions at the European Society for Medical Oncology in Vienna, Austria. [Merrimack Pharmaceuticals, Inc.] Press Release |
| JOB OPPORTUNITIES | Scientist – Endothelial Cells (STEMCELL Technologies, Inc.) Scientist – Epithelial Cell Research (STEMCELL Technologies, Inc.) Scientist – Hematology (STEMCELL Technologies, Inc.) Scientist – hPSC (STEMCELL Technologies, Inc.) Scientist – Induced Pluripotent Stem Cells (STEMCELL Technologies, Inc.) Scientist – hPSC Bioengineering (STEMCELL Technologies, Inc.) Scientist – Antibody and Hybridoma Technology Platforms (STEMCELL Technologies, Inc.) Business Analyst – Product Management (STEMSOFT Software, Inc.) Clinical Research Associate (Jennerex Biotherapeutics, Inc.) Research Associate – Development (Precision Therapeutics, Inc.) Postdoctoral Fellow (Louisiana State University Health Sciences Center) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost. Jobs are categorized regionally: United States, Canada, Europe, Middle East to Asia Pacific Visit here to post your career opportunities. |
|
|
|